Cargando…
Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
Metabolic alterations precede cardiometabolic disease onset. Here we present ceramide- and dihydroceramide-profiling data from a nested case-cohort (type 2 diabetes [T2D, n = 775]; cardiovascular disease [CVD, n = 551]; random subcohort [n = 1137]) in the prospective EPIC-Potsdam study. We apply the...
Autores principales: | Wittenbecher, C., Cuadrat, R., Johnston, L., Eichelmann, F., Jäger, S., Kuxhaus, O., Prada, M., Del Greco M., F., Hicks, A. A., Hoffman, P., Krumsiek, J., Hu, F. B., Schulze, M. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854598/ https://www.ncbi.nlm.nih.gov/pubmed/35177612 http://dx.doi.org/10.1038/s41467-022-28496-1 |
Ejemplares similares
-
Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation
por: Eichelmann, Fabian, et al.
Publicado: (2022) -
Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study
por: Prada, Marcela, et al.
Publicado: (2023) -
Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort
por: Prada, Marcela, et al.
Publicado: (2022) -
Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors
por: Wittenbecher, Clemens, et al.
Publicado: (2019) -
Demographic and clinical variables affecting mid‐ to late‐life trajectories of plasma ceramide and dihydroceramide species
por: Mielke, Michelle M., et al.
Publicado: (2015)